Million-Heart Dataset Deal Positions Australian Startup at Forefront of AI Cardiac Diagnostics Race
EchoIQ's exclusive access to up to one million echocardiogram scans represents one of the largest cardiovascular imaging datasets secured for AI development in the Asia-Pacific region.
Why Your Hospital's AI Dreams May Be Failing Before They Start: The Infrastructure Gap No One Talks About
Most hospital AI projects fail not because the technology is flawed, but because foundational data infrastructure wasn't built first.
Nvidia, Abridge collaborate to develop healthcare-specific AI model
The partnership aims to create a purpose-built foundation model for clinical conversations, moving beyond adapted general-purpose AI to address unique medical communication challenges.
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.
OpenEvidence Launches Voice Mode and Closes $250M Series D at $12 Billion Valuation
OpenEvidence has launched a hands-free Voice Mode for its AI-powered medical search platform and disclosed a $250 million Series D round at a $12 billion valuation, backed by Google Ventures, Nvidia, Thrive Capital, and Mayo Clinic.
KFF Report Warns AI Could Exacerbate Racial Health Disparities Without Targeted Intervention
A new report from KFF (Kaiser Family Foundation) finds that AI systems deployed in clinical settings could widen existing racial and ethnic health disparities if not designed, validated, and monitored with equity as an explicit objective.